We are live on ! Find out more
LWCFA

Loring Wolcott & Coolidge Fiduciary Advisors Portfolio holdings

AUM $10.3B
1-Year Est. Return 3.26%
This Fund
S&P 500
This Quarter Est. Return
+5.61%
1 Year Est. Return
+3.26%
3 Year Est. Return
+43.63%
5 Year Est. Return
+56.22%
10 Year Est. Return
+342.64%
AUM
$6.87B
AUM Growth
+$293M
Cap. Flow
-$27.5M
Cap. Flow %
-0.4%
Top 10 Hldgs %
41.13%
Holding
788
New
49
Increased
119
Reduced
169
Closed
61

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$36.3M
2
BDX icon
Becton Dickinson
BDX
+$22.1M
3
DIS icon
Walt Disney
DIS
+$14.3M
4
CRM icon
Salesforce
CRM
+$13.3M
5
PG icon
Procter & Gamble
PG
+$12.2M

Top Sells

Rank Stock Value
1
CTSH icon
Cognizant
CTSH
+$27.4M
2
CELG
Celgene Corp
CELG
+$25.2M
3
MA icon
Mastercard
MA
+$13.5M
4
CL icon
Colgate-Palmolive
CL
+$12.3M
5
META icon
Meta Platforms (Facebook)
META
+$12.1M

Sector Composition

Rank Sector Weight
1 Technology 31.84%
2 Healthcare 16.83%
3 Financials 11.71%
4 Consumer Discretionary 10.58%
5 Consumer Staples 7.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TAK icon
526
Takeda Pharmaceutical
TAK
$55.6B
$16K ﹤0.01%
911
AMD icon
527
Advanced Micro Devices
AMD
$788B
$15K ﹤0.01%
500
AR icon
528
Antero Resources
AR
$11.5B
$15K ﹤0.01%
2,750
AZO icon
529
AutoZone
AZO
$49.7B
$15K ﹤0.01%
+14
New +$14.7K
CNX icon
530
CNX Resources
CNX
$5.29B
$15K ﹤0.01%
2,000
COO icon
531
Cooper Companies
COO
$15B
$15K ﹤0.01%
176
+60
+52% +$4.51K
EXAS
532
DELISTED
Exact Sciences
EXAS
$15K ﹤0.01%
129
+84
+187% +$8.46K
GPN icon
533
Global Payments
GPN
$23.4B
$15K ﹤0.01%
92
+74
+411% +$11K
KEY icon
534
KeyCorp
KEY
$24.5B
$15K ﹤0.01%
820
MANH icon
535
Manhattan Associates
MANH
$11.2B
$15K ﹤0.01%
210
PETS icon
536
PetMed Express
PETS
$43M
$15K ﹤0.01%
975
ATNI icon
537
ATN International
ATNI
$478M
$14K ﹤0.01%
250
DXC icon
538
DXC Technology
DXC
$1.71B
$14K ﹤0.01%
248
EPAM icon
539
EPAM Systems
EPAM
$5.17B
$14K ﹤0.01%
+80
New +$13.8K
HBAN icon
540
Huntington Bancshares
HBAN
$36.1B
$14K ﹤0.01%
1,000
ICE icon
541
Intercontinental Exchange
ICE
$85B
$14K ﹤0.01%
164
+83
+102% +$6.78K
MET icon
542
MetLife
MET
$61.4B
$14K ﹤0.01%
283
ABB
543
DELISTED
ABB Ltd
ABB
$14K ﹤0.01%
720
XLRN
544
DELISTED
Acceleron Pharma
XLRN
$14K ﹤0.01%
337
CHK
545
DELISTED
Chesapeake Energy Corporation
CHK
$14K ﹤0.01%
35
MCHP icon
546
Microchip Technology
MCHP
$43.1B
$13K ﹤0.01%
306
+210
+219% +$9.33K
PNR icon
547
Pentair
PNR
$10.5B
$13K ﹤0.01%
354
+54
+18% +$2.05K
KDP icon
548
Keurig Dr Pepper
KDP
$40.2B
$12K ﹤0.01%
400
KIM icon
549
Kimco Realty
KIM
$16.2B
$12K ﹤0.01%
655
LMT icon
550
Lockheed Martin
LMT
$140B
$12K ﹤0.01%
33

Similar funds

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2019 Portfolio in Review

As of Q2 2019, Loring Wolcott & Coolidge Fiduciary Advisors held 788 positions worth $6.87B, up 4.5% from $6.58B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Loring Wolcott & Coolidge Fiduciary Advisors's Q2 2019 filing shows 49 new, 119 increased, 169 reduced and 61 closed positions. Its largest new stake was Amcor: 91,695 shares worth $5.27M. The largest sale was Cognizant, an estimated $27.4M.

By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

  • Loring Wolcott & Coolidge Fiduciary Advisors's largest Q2 2019 buy was Amcor: 91,695 shares worth $5.27M.
  • Loring Wolcott & Coolidge Fiduciary Advisors added most to Amazon in Q2 2019, an estimated $36.3M increase.
  • Loring Wolcott & Coolidge Fiduciary Advisors's biggest Q2 2019 reduction was Cognizant, cutting an estimated $27.4M.
  • Loring Wolcott & Coolidge Fiduciary Advisors fully exited Bemis in Q2 2019, selling an estimated $6.02M.
  • Loring Wolcott & Coolidge Fiduciary Advisors's ten largest holdings make up 41% of its $6.87B portfolio in Q2 2019.
  • Loring Wolcott & Coolidge Fiduciary Advisors opened 49 new positions and closed 61 in Q2 2019.
  • Loring Wolcott & Coolidge Fiduciary Advisors's portfolio value rose 4.5% quarter-over-quarter to $6.87B.

Based on Loring Wolcott & Coolidge Fiduciary Advisors's 13F filing for Q2 2019, filed 9 Aug 2019.